Found 0 matching trials
Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis PHASE3 The study will assess the safety and efficacy of intravenous (10mg/kg) and ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate PHASE2 The study compared the efficacy and assessed the safety of secukinumab give...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients PHASE1 Given the role of IL-17 in the development of entheseal-driven pathology, a...
Show More Location
Chinese Academy of Medical Sciences & Peking Union Medical College
Learn More & Join Trial
Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis PHASE3 This study will assess the safety and efficacy of AIN457 as adjunctive ther...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents PHASE3 The core and extension studies assessed the safety and efficacy of secukinu...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Extension in AS: Sustainability of Benefits, Safety and Tolerability PHASE3 This 3-year extension study aims at making available the treatment with sec...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis PHASE3 This study will assess the safety and efficacy of secukinumab compared to p...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects PHASE1 It is a randomized, double-blinded, single-dose, 3-arm parallel, comparativ...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis PHASE3 This study will assess the safety and efficacy of AIN457 as adjunctive ther...
Show More Location
Sall Research Medical Center
Learn More & Join Trial
Effect of Secukinumab in the Treatment of Psoriatic Arthritis PHASE2 The investigators propose an open label pragmatic clinical and laboratory s...
Show More Location
Aintree University Hospitals NHS Foundation Trust
Learn More & Join Trial